newsfilter
← Latest News
CNBC·

The UK's National Health Service just approved a drug that costs nearly $2.5 million a dose

The innovative gene therapy called "Zolgensma" does not come cheap, with a reported list price of £1.79 million ($2.48 million) per dose.